INTERCEPT PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07J STEROIDS163
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9777038 Process for preparing bile acid derivativesOct 25, 13Oct 03, 17[C07J]
9763964 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditionsJun 18, 15Sep 19, 17[A61K, C07J]
9732116 Preparation and uses of obeticholic acidNov 20, 15Aug 15, 17[A61K, C07J]
9732117 Steroids as agonists for FXRFeb 05, 16Aug 15, 17[C07C, C07J]
9650409 TGR5 modulators and methods of use thereofApr 26, 13May 16, 17[A61K, C07J]
9611289 Farnesoid X receptor modulatorsMay 14, 14Apr 04, 17[A61K, C07J]
9540414 TGR5 modulators and methods of use thereofAug 01, 14Jan 10, 17[A61K, C07J]
9498484 Treatment of fibrosis using FXR ligandsMar 14, 05Nov 22, 16[A61K]
9243027 TGR5 modulators and methods of use thereofApr 01, 13Jan 26, 16[A61K, C07J]
9238673 Preparation and uses of obeticholic acidJun 17, 13Jan 19, 16[A61K, C07J]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0166,598 Steroids as Agonists for FXRAbandonedFeb 26, 15Jun 18, 15[C07J]
2014/0148,428 Treatment of Pulmonary DiseaseAbandonedNov 26, 13May 29, 14[C07J]
2006/0252,670 Method of reducing drug-induced adverse side effects in a patientAbandonedOct 13, 05Nov 09, 06[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.